| Dow | 13387.82 | -47.39 | (-0.35%) |
| Nasdaq | 3094.97 | -6.69 | (-0.22%) |
| SP 500 | 1460.38 | -6.09 | (-0.42%) |
| 10-yr Note | -1/32 | 1.906 | |
| NYSE | Adv 1128 | Dec 1718 | Vol 176.8 mln |
| Nasdaq | Adv 921 | Dec 1431 | Vol 522.5 mln |
| Strong: Health Care, Materials |
| Weak: Telecoms, Consumer Discretionary |
![]() |
Fourth quarter earnings season will begin with an after-hours report from Alcoa (AA). |
The health care sector is the lone advancer as companies specializing in health care technology lead the space. Allscripts Healthcare (MDRX 9.59, +0.22) is rising by 2.4% after Avondale upgraded the stock to ‘Outperform.' Elsewhere, Quality Systems (QSII 17.94, +0.55) is firmer by 3.1%. Earlier, NextGen Healthcare Information Systems, which is a wholly owned subsidiary of QSII, announced it has entered into a strategic agreement with Medline Industries to expand its integrated solutions.
Also of note, Viropharma (VPHM 24.90, +1.14) is rising by 4.8% after the company issued full-year 2013 guidance in-line with the Capital IQ consensus estimate.







